Health Catalyst (HCAT) director awarded 12,710 RSUs, now holds 94,644 shares

Rhea-AI Filing Summary

Larson-Green Julie reported acquisition or exercise transactions in this Form 4 filing.

Health Catalyst, Inc. director Julie Larson-Green received an equity grant of 12,710 shares of common stock in the form of restricted stock units. The award was granted under the company’s 2019 Stock Option and Incentive Plan at no cash cost and vested in full on June 1, 2026. Following this compensation grant, she directly holds 94,644 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Larson-Green Julie

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,710	$0.00	--

Holdings After Transaction: Common Stock — 94,644 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 12,710 shares Grant price per share: $0.00 per share Shares held after grant: 94,644 shares +2 more

5 metrics

RSU grant size 12,710 shares Restricted stock units granted to director on June 1, 2026

Grant price per share $0.00 per share Non-cash equity award; no purchase price paid

Shares held after grant 94,644 shares Total direct common stock holdings after RSU vesting

Vesting date June 1, 2026 100% of the 12,710 RSUs vested on this date

RSU-to-share ratio 1 RSU : 1 share Each RSU represents a contingent right to one share

Key Terms

restricted stock units ("RSUs"), 2019 Stock Option and Incentive Plan, Non-Employee Director Compensation Policy

3 terms

restricted stock units ("RSUs") financial

"Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2019 Stock Option and Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan")."

Non-Employee Director Compensation Policy financial

"in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested..."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larson-Green Julie

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		12,710(1)	A	$0.00	94,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on June 1, 2026.

Remarks:

	/s/Benjamin Landry, as Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Health Catalyst (HCAT) director Julie Larson-Green report in this Form 4?

Julie Larson-Green reported receiving 12,710 restricted stock units of Health Catalyst common stock as a compensation grant. The award was made under the company’s 2019 Stock Option and Incentive Plan and is a non-cash equity grant rather than an open-market purchase.

How many Health Catalyst (HCAT) shares does Julie Larson-Green hold after this transaction?

After the grant of 12,710 restricted stock units, Julie Larson-Green directly holds 94,644 shares of Health Catalyst common stock. This figure reflects her updated ownership position reported in the Form 4 following the equity award’s vesting on June 1, 2026.

What kind of equity award did Health Catalyst (HCAT) grant to Julie Larson-Green?

She received an award of restricted stock units, or RSUs, where each unit represents a contingent right to one share of common stock. The grant was issued under Health Catalyst’s 2019 Stock Option and Incentive Plan as part of non-employee director compensation.

When did Julie Larson-Green’s Health Catalyst (HCAT) RSU grant vest?

The 12,710 restricted stock units vested 100% on June 1, 2026, in line with Health Catalyst’s Non-Employee Director Compensation Policy. Upon vesting, each RSU converted into one share of common stock, increasing her directly held share count.

Did Julie Larson-Green buy or sell Health Catalyst (HCAT) shares on the market?

No open-market buy or sell occurred in this Form 4. The filing reports a grant of 12,710 restricted stock units as director compensation, with no purchase price per share and no sale transactions disclosed in connection with this award.